REG - Optima Health PLC - Appointment of Joint Broker

Optima HealthAnnouncement

16/02/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260216:nRSP0429Ta&default-theme=true

RNS Number : 0429T  Optima Health PLC  16 February 2026

16 February 2026

Optima Health plc

("Optima", the "Company", and, together with its subsidiaries, the "Group")

Appointment of Joint Broker

Optima Health (AIM: OPT), the UK's leading provider of technology enabled
corporate health and wellbeing solutions, announces the appointment of
Cavendish Capital Markets Limited ("Cavendish") as joint broker to the Company
with immediate effect.

Cavendish will work alongside Panmure Liberum, the Group's existing nominated
adviser and corporate broker.

 

  Enquiries

 Optima Health                                       +44(0)3300085113

 Jonathan Thomas, CEO                                media@OptimaHealth.co.uk

 Heidi Giles, CFO

 Panmure Liberum Limited                             +44 (0)20 3100 2000

 Nominated Adviser and Corporate Broker

 Emma Earl / Will Goode/ Mark Rogers

 Rupert Dearden

 Cavendish Capital Markets                           + 44 (0)20 7220 0500

 Joint Broker

 Geoff Nash/Ben Jeynes/George Lawson

 Julian Morse/Michael Johnson/Nigel Birks

 ICR Healthcare                                      optimahealth@icrinc.com

 UK Financial PR Adviser

 Mary-Jane Elliott / Angela Gray / Lindsey Neville

 

About Optima Health

Optima Health is the UK's leading provider of occupational health and
wellbeing services, delivering clinically led, technology-driven solutions to
organisations across the public and private sectors. With a team of more than
1,600 including 800 clinicians, Optima Health supports millions of employees
and operates from a network of more than 50 clinics nationwide.

 In addition to its core UK market, Optima Health also operates
in Ireland under Optima Health Ireland, providing occupational health
services to clients nationwide.

 

For more information visit www.optimahealth.co.uk
(http://www.optimahealth.co.uk/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPFLFVDFRIELIR



            Copyright 2019 Regulatory News Service, all rights reserved